// App-Quantinova.ai

Mo2004 : Development of Obesity, Insulin Resistance and Metabolic Derangements in Mice Overexpressing Sar1b Whose Mutation Causes Chylomicron Retention Disease

Researchers

Presenter

  • Carole Garofalo

Principal Investigators

  • Lea Emonnot

  • Valerie Marcil

  • Alain Montoudis

  • Edgard Delvin

  • Rocio Sanchez

  • Daniel Sinnett

  • Ernest G. Seidman

  • Alain T. Sane

  • Emile Levy

Medical Centers

  • Pediatrics, University of Montreal, Montreal, Canada

  • Research Center CHU Sainte Justine, Montreal, QC, Canada

  • Research Institute, McGill University, Quebec, QC, Canada

  • School of Rehabilitation, University of Montreal, Montreal, QC, Canada

  • Pharmacy, Universite de Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Chylomicron retention disease

  • Fatty Liver Disease

  • Obesity

Biomarkers

  • Insulin

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved